This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Nov 1;8(12):692.

doi: 10.1038/nrclinonc.2011.162.

Prevention: vitamin E leaves bitter aftertaste

Christoph A Schmitt

PMID: 22048621
DOI: 10.1038/nrclinonc.2011.162

Comment

Prevention: vitamin E leaves bitter aftertaste

Christoph A Schmitt. Nat Rev Clin Oncol. 2011.

. 2011 Nov 1;8(12):692.

doi: 10.1038/nrclinonc.2011.162.

Author

Christoph A Schmitt

PMID: 22048621
DOI: 10.1038/nrclinonc.2011.162

No abstract available

PubMed Disclaimer

Comment on

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH. Klein EA, et al. JAMA. 2011 Oct 12;306(14):1549-56. doi: 10.1001/jama.2011.1437. JAMA. 2011. PMID: 21990298 Free PMC article. Clinical Trial.

References

1. JAMA. 2011 Oct 12;306(14):1549-56 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database